Zealand, Roche's obesity drug helps patients lose up to 9.2% weight in mid-stage trial

Zealand Pharma said on Wednesday its experimental drug helped people who are overweight or ​obese and have type 2 diabetes ‌lose up to 9.2% of their body weight in a mid-stage trial. The Danish compan...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。